Marathon Pharmaceuticals - Emflaza's Unit Acquisition

Marathon Pharmaceuticals - Emflaza raised a round of funding on March 16, 2017. Investors include PTC Therapeutics.

Marathon Pharmaceuticals is a biopharmaceutical company that develops treatments for rare diseases, with a focus on patients who currently have no treatment options. Emflaza reduces inflammation, whic…

Articles about Marathon Pharmaceuticals - Emflaza's Unit Acquisition: